A Medicare Drug Subsidy Is Ending—Here’s What Patients Should Know
TL;DR AI
2 min readKey summary
CMS will end the temporary Part D Premium Stabilization Demonstration after 2026.
The subsidy helped keep Medicare drug-plan premiums lower for about 25 million people after Inflation Reduction Act changes triggered premium spikes.
CMS says insurers now have enough experience to price plans without federal support.
Monthly premiums for many stand-alone Part D enrollees are likely to rise starting in January 2027, increasing prescription drug costs for millions.